129 related articles for article (PubMed ID: 1934528)
1. GH response to growth hormone releasing hormone and hypoglycaemia is unaltered by high endogenous plasma calcitonin levels in patients with medullary thyroid carcinoma.
Popovic V; Micic D; Damjanovic S; Durbaba M; Petakov M; Zoric S; Djurovic M; Manojlovic D; Micic J
Clin Endocrinol (Oxf); 1991 Aug; 35(2):137-9. PubMed ID: 1934528
[TBL] [Abstract][Full Text] [Related]
2. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia.
Beentjes JA; Tjeerdsma G; Sluiter WJ; Dullaart RP
Clin Endocrinol (Oxf); 1996 Oct; 45(4):391-8. PubMed ID: 8959076
[TBL] [Abstract][Full Text] [Related]
3. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin release from medullary thyroid carcinoma by thyrotropin-releasing hormone: comparison with calcium injection.
Oishi S; Yamauchi J; Fujimoto Y; Hamasaki S; Umeda T; Sato T
Acta Endocrinol (Copenh); 1992 Apr; 126(4):325-8. PubMed ID: 1595326
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone releasing hormone 1-44 NH2 and 1-40 OH levels in normal subjects during growth hormone stimulation tests.
Page MD; Dieguez C; Valcavi R; Koppeschaar HP; Scanlon MF
Clin Endocrinol (Oxf); 1994 Jan; 40(1):97-102. PubMed ID: 8306488
[TBL] [Abstract][Full Text] [Related]
6. The effect of calcitonin on growth hormone secretion in man.
Looij BJ; Roelfsema F; van der Heide D; Frölich M; Souverijn JH; Nieuwenhuijzen Kruseman AC
Clin Endocrinol (Oxf); 1988 Nov; 29(5):517-27. PubMed ID: 2908103
[TBL] [Abstract][Full Text] [Related]
7. Impaired growth hormone response to growth hormone releasing factor and insulin-hypoglycaemia in obesity.
Kopelman PG; Noonan K; Goulton R; Forrest AJ
Clin Endocrinol (Oxf); 1985 Jul; 23(1):87-94. PubMed ID: 2863016
[TBL] [Abstract][Full Text] [Related]
8. Effects of intranasal calcitonin administration on pituitary GH response to hGHRH (1-29)NH2 in normal adult subjects.
Giustina A; Romanelli G; Doga M; Pizzocolo G; Giustina G
Clin Endocrinol (Oxf); 1989 Jun; 30(6):699-704. PubMed ID: 2556224
[TBL] [Abstract][Full Text] [Related]
9. Influence of hyperthyroidism on growth hormone secretion.
Valcavi R; Dieguez C; Zini M; Muruais C; Casanueva F; Portioli I
Clin Endocrinol (Oxf); 1993 May; 38(5):515-22. PubMed ID: 8330446
[TBL] [Abstract][Full Text] [Related]
10. A divergence of plasma growth hormone response between growth hormone-releasing factor and insulin-induced hypoglycaemia among middle-aged healthy male subjects.
Wakabayashi I; Shibasaki T; Ling N
Clin Endocrinol (Oxf); 1986 Mar; 24(3):279-83. PubMed ID: 3085999
[TBL] [Abstract][Full Text] [Related]
11. Effects of calcitonin on GH response to pyridostigmine in combination with hGHRH (1-29) NH2 in normal adult subjects.
Giustina A; Bodini C; Bossoni S; Doga M; Girelli A; Pizzocolo G; Wehrenberg WB
Clin Endocrinol (Oxf); 1990 Sep; 33(3):375-80. PubMed ID: 2147598
[TBL] [Abstract][Full Text] [Related]
12. Absence of desensitization by hexarelin to subsequent GH releasing hormone-mediated GH secretion in patients with anorexia nervosa.
Popovic V; Micic D; Djurovic M; Obradovic S; Casanueva FF; Dieguez C
Clin Endocrinol (Oxf); 1997 May; 46(5):539-43. PubMed ID: 9231048
[TBL] [Abstract][Full Text] [Related]
13. Thyrotrophin releasing hormone induced calcitonin secretion in patients with medullary carcinoma of the thyroid.
Nakamura H; Someda H; Mori T; Imura H
Clin Endocrinol (Oxf); 1987 Jul; 27(1):69-74. PubMed ID: 3115636
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone does not inhibit its own secretion during prolonged hypoglycemia in man.
Barbetti F; Crescenti C; Negri M; Leonetti F; Grossi A; Tamburrano G
J Clin Endocrinol Metab; 1990 May; 70(5):1371-4. PubMed ID: 2110574
[TBL] [Abstract][Full Text] [Related]
15. Effects of glucocorticoid treatment and acute passive immunization with growth hormone-releasing hormone and somatostatin antibodies on endogenous and stimulated growth hormone secretion in the male rat.
Miell J; Corder R; Miell PJ; McClean C; Gaillard RC
J Endocrinol; 1991 Oct; 131(1):75-86. PubMed ID: 1683888
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin inhibition of growth hormone-releasing hormone-induced GH secretion in normal men.
Ceda GP; Denti L; Ceresini G; Rastelli G; Dotti C; Cavalieri S; Valenti G; Hoffman AR
Acta Endocrinol (Copenh); 1989 Apr; 120(4):416-22. PubMed ID: 2541589
[TBL] [Abstract][Full Text] [Related]
17. The pituitary gland is capable of responding to two successive doses of growth hormone releasing hormone (GHRH).
Suri D; Hindmarsh PC; Matthews DR; Brain CE; Brook CG
Clin Endocrinol (Oxf); 1991 Jan; 34(1):13-7. PubMed ID: 2004468
[TBL] [Abstract][Full Text] [Related]
18. The sequential administration of growth hormone-releasing hormone followed 120 minutes later by hexarelin, as an effective test to assess the pituitary GH reserve in man.
Micic D; Popovic V; Kendereski A; Peino R; Dieguez C; Casanueva FF
Clin Endocrinol (Oxf); 1996 Nov; 45(5):543-51. PubMed ID: 8977750
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules.
Rieu M; Lame MC; Richard A; Lissak B; Sambort B; Vuong-Ngoc P; Berrod JL; Fombeur JP
Clin Endocrinol (Oxf); 1995 May; 42(5):453-60. PubMed ID: 7621562
[TBL] [Abstract][Full Text] [Related]
20. Calcitonin suppresses growth hormone (GH) response to growth hormone-releasing hormone (GHRH) in man.
Lengyel AM; Toledo AL; Czepielewski MA; Vieira JG; Chacra AR
J Endocrinol Invest; 1989 Jan; 12(1):25-9. PubMed ID: 2545765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
